TCBIO
TEXAS CAPITAL BANCSHARES INC/TX
NASDAQ · Financial Services · Banks - Regional · US
$18.28
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.9B | 2.0B | 1.8B | 1.0B | 1.2B |
| Cost of Revenue | 565.8M | 798.1M | 895.3M | — | — |
| Gross Profit | 942.0M | 1.2B | 865.3M | 1.0B | 1.2B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 402.7M | 515.9M | 512.3M | 522.3M | 481.6M |
| General & Admin Expense | 383.3M | 498.4M | 489.9M | 496.5M | 449.3M |
| Selling & Marketing Expense | 19.4M | 17.4M | 22.3M | 25.9M | 32.4M |
| Other Expenses | 200.6M | 252.2M | 246.0M | 553.2M | (248.4M) |
| Total Operating Expenses | 603.3M | 768.1M | 758.3M | 1.1B | (727.5M) |
| Cost and Expenses | 1.2B | 1.6B | 1.7B | 1.1B | (727.5M) |
| Operating Income (EBIT) | 338.7M | 432.7M | 286.6M | 246.6M | 369.2M |
| Non-Operating | |||||
| Interest Income | 1.3B | 1.8B | 1.7B | 1.6B | 1.1B |
| Interest Expense | 724.7M | 743.1M | 828.3M | 715.8M | 268.5M |
| Net Interest Income | 782.5M | 1.0B | 901.3M | 914.1M | 875.8M |
| Other Non-Op Income/Expense | — | — | — | — | (70.9M) |
| Non-Operating Income (excl Interest) | — | — | — | — | 70.9M |
| EBT (Pre-Tax Income) | 474.4M | 432.7M | 107.1M | 246.6M | 431.8M |
| Income Tax Expense | 111.3M | 102.5M | 29.6M | 57.5M | 99.3M |
| Bottom Line | |||||
| Net Income | 363.1M | 330.2M | 77.5M | 189.1M | 332.5M |
| Earnings from Cont. Ops | 363.1M | 330.2M | 77.5M | 189.1M | 332.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 350.2M | 313.0M | 60.3M | 171.9M | 315.2M |
| Per Share | |||||
| Basic EPS | $7.92 | $6.86 | $1.29 | $3.54 | $6.25 |
| Diluted EPS | $7.86 | $6.79 | $1.28 | $3.54 | $6.18 |
| Revenue Per Share | $42.75 | $43.80 | $38.14 | $20.64 | $22.98 |
| Shares | |||||
| Basic Shares Outstanding | 43.6M | 45.6M | 46.2M | 48.6M | 50.5M |
| Diluted Shares Outstanding | 43.6M | 46.1M | 46.6M | 48.6M | 51.0M |
| Profitability Metrics | |||||
| EBITDA | 382.9M | 484.9M | 340.9M | 287.1M | 477.0M |
| D&A | 44.2M | 52.2M | 54.2M | 40.5M | 45.3M |
| EBIT | 338.7M | 432.7M | 286.6M | 246.6M | 431.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026